PhD: Understanding and Engineering the Cellular Properties of G-Quadruplex Ligands

PhD: Understanding and Engineering the Cellular Properties of G-Quadruplex Ligands

Why can molecules with similar affinity for G-quadruplex structures outside cells produce different cellular effects? The Dennis Gomez–Anne Petitjean project addresses that question within the first BEST doctoral call: Understanding and Engineering the Cellular Properties of G-Quadruplex Ligands, hosted at IPBS, CNRS/University of Toulouse, France. The individual thesis PDF identifies the opportunity; the shared nineteen-award call and common application portal do not identify nineteen interchangeable versions of it. The specific offer describes a 36-month doctoral contract starting September/October 2027, with applications due 23 November 2026. [S01–S03]

The opportunity merits a serious application from a master's graduate with DNA-repair or nucleic-acid-structure experience who wants to connect chemical recognition with cellular mechanism. It is a less direct fit for an applicant seeking a mainly computational doctorate, clinical training, or organic synthesis without cell-biological interpretation. Funding is described as a doctoral employment award, but this applicant has not been offered a contract. Published programme-level pay is indicative and its payroll details still need confirmation.

Research question and evidence

The central scientific problem is that small molecules with similar affinity for G4 structures outside cells can produce substantially different cellular responses. The project aims to connect ligand structure, cellular localisation, protein partners and DNA-damage or transcription/replication phenotypes. It builds on the laboratory's TOP2A-associated G4 mechanism work and proposes to compare ligand families rather than assume that G4 binding alone explains cellular activity. The PDF's clinical-development references are scientific motivation; this dossier does not independently verify trial status or recommend treatment. [S01, S04]

The broader frontier is causal target engagement: determining what a probe recognises under relevant conditions, whether it perturbs the structure being measured, and which molecular event explains the phenotype. A useful applicant can distinguish binding, structural stabilisation, cellular localisation and downstream response. Three recent original studies were read to different, explicitly bounded depths:

Boissieras and colleagues (2024): probe specificity

Boissieras et al., Nucleic Acids Research, 2024, iMab specificity. Selected primary methods/results and author notes were read. BLI, circular dichroism, pull-down and bulk-FRET measurements compare C-rich sequences and structural states. The data challenge the interpretation that iMab staining uniquely reports folded i-motifs: binding can track sequence composition, and the probe can unfold the structure. Gomez is a coauthor; Boissieras and Bonnet are joint first authors, while Granzhan and Dejeu are the designated correspondents. Gomez's individual experimental duties were not specified in the read material. For this thesis, the lesson is to validate molecular readouts with independent evidence rather than interpret a bright signal as proof of a target. Supplements and raw data were not inspected. [S09]

Pipier and colleagues (2024): a junction-ligand comparison

Pipier et al., Angewandte Chemie, 2024, three-way DNA junction ligands. The formal abstract, author list and selected indexed publisher-body passages were read. Competitive melting/selectivity, functional DNA-polymerase response and MD/NMR evidence converge on two promising azacryptands; NMR observations in cell extracts support specificity under a more complex environment. Such extracts do not establish intracellular localisation or a complete cellular mechanism. Britton and Caroff are coauthors; Monchaud and Granzhan are correspondents. Neither Gomez nor Petitjean is an author. This is collaboration-network evidence and a methodological comparison, not a supervisor-owned G4 result. Direct full-body and institutional PDF retrieval failed; supporting information was not read. [S10]

Demange and colleagues (2022): activation versus overall response

Demange et al., eLife, 2022, SDR-dependent small-molecule activity. Selected indexed primary results, the reviewer/author response and institutional author-contribution text were read. Human-cell chemical genetics, chemistry and proteomic evidence connect an enzyme-dependent activation step to protein modification and cellular stress. The review highlights unresolved identification of the particular protein targets that cause the overall response, limiting a simple target-to-phenotype narrative. Britton is a corresponding author with conceptualisation, supervision, investigation and writing responsibilities in the contribution statement; Gomez and Petitjean are absent. This different chemical class illustrates the host team's mechanism-discovery strategy, not proof that the same mechanism applies to G4 ligands. Direct full-text/PDF attempts were blocked or rate-limited. [S11]

Petitjean's Miron et al. 2022 platinum G4 family paper provides a fourth, narrower reference. The original abstract and institutional author record were read: chemical-family development and preliminary biophysical screening support improved G4-versus-duplex selectivity for most family members. Full assay methods and numeric data were inaccessible, so stronger mechanistic claims are unwarranted. Petitjean is marked corresponding author in her institutional publication list; Gomez is not an author. [S07–S08]

Together these studies justify the project's emphasis on orthogonal measurements and careful interpretation. They do not promise a clinically useful molecule, a predefined successful mechanism or a particular number of papers. A strong thesis could still emerge from establishing why an apparently selective probe behaves differently in cells, provided the question and negative-result standards are well defined.

School, field and doctoral training

IPBS provides a relevant institutional setting: a joint CNRS/university laboratory, with DNA-repair research, chemical-biology collaboration and imaging/proteomic infrastructure in Toulouse. This project's health-and-wellbeing theme fits TIRIS's stated interdisciplinary framework. The central BEST page specifies nineteen awards in its first cohort, within a thirty-seven-award programme across two cohorts; those are programme totals rather than nineteen places in Gomez's group. It also requires international co-supervision and integrated mobility in a partner laboratory. [S02–S04, S12–S14]

The university's interpretation of ARWU 2026 places it in the 301–400 global band, explaining that the ranking uses 2025 data for Toulouse III–Paul Sabatier. That historical reporting identity matters when comparing renamed institutions. It is a university-level publication signal, not a ranking of G4 chemistry or this supervisor. The article's highlighted earth and atmospheric science strengths do not establish excellence in the proposed molecular topic. For this application, the direct fit between the project, local facilities and the two supervisors is more informative than borrowing an unrelated subject ranking. [S24]

The international arrangement offers potential access to two complementary scientific cultures: cellular DNA-damage mechanisms in Toulouse and molecular recognition chemistry at Queen's University in Ontario. The offer does not establish a joint or double degree, a Canadian employment contract, or a specified duration in Canada. Confirm the doctoral school, awarding institution, legal employer, supervision agreement and mobility schedule before interpreting the partnership as a particular degree pathway. French official guidance explicitly distinguishes the employer, funder and degree-awarding institution. [S01, S03, S05–S06, S17–S18]

The institutional setting aligns with the proposed methods. The uncertainty concerns the individual training arrangement, not whether the named laboratories exist. No verified programme placement rate or candidate-to-place ratio was obtained.

Supervisors and laboratory support

The IPBS team page identifies Sébastien Britton as group leader and Dennis Gomez as a CNRS research scientist. Gomez is the named Toulouse supervisor for this thesis; he should not be relabelled as the overall laboratory head. Anne Petitjean's current Queen's faculty profile identifies her as Full Professor, with work spanning supramolecular and biological chemistry. An older group-card title is not used to downgrade that current role. David Monchaud is named in the project as a contributing chemist supplying benchmark ligands and derivatives; the PDF does not designate him as a third formal supervisor. [S01, S04–S07]

Gomez's molecular expertise is substantiated by the team's G4 and DNA-structure work and by his authorship of the 2024 iMab specificity study. The team lists a 2025 SEA-iDNA collaboration involving Gomez, alongside broader laboratory funding. This is evidence of an active research network, not proof that any particular grant pays BEST consumables or a fourth doctoral year. Petitjean's selected publication list substantiates platinum-based G4 recognition research. It is explicitly selective and cannot support an h-index, publication frequency, student completion rate or current mentoring load. [S04, S07–S09]

The local core-facility overview lists ProteoToul, PICT and partner microscopy/cytometry resources. The national imaging infrastructure describes a relevant chromatin and DNA-damage imaging service, including super-resolution and image analysis. These support the feasibility of the advertised imaging and chemoproteomics direction, but they do not prove guaranteed instrument hours, free access, specialist support allocated to this student, or that every advertised instrument will be used. Confirm who handles training, image analysis and proteomic interpretation, and how the joint supervision divides scientific decisions. [S12–S13]

The supervisors offer complementary expertise. The most decision-relevant remaining evidence is practical: meeting frequency, training ownership, expected independence, handling of failed mechanistic hypotheses and the division of time between countries. Scientific reputation does not substitute for these mentoring details.

Funding and Toulouse living costs

The specific project and native call offer a 36-month doctoral contract. A university-authored programme employment notice describes an approximate €2,800 monthly “net … before income tax” salary and a €350 monthly travel/mobility allowance. That unusual payroll wording is important: it is not a confirmed personal amount after income tax, and the gross salary, deductions, allowance treatment and whether the allowance is additional remain unverified. The notice carries an expired platform badge while the IPBS and central BEST pages described the call as open at the original assessment. Its funding detail is useful but should be confirmed against the applicant guide and eventual contract. The guide’s salary chapters remain unreviewed; the payroll terms require confirmation. [S01–S03, S15]

France's public doctoral minimum is €2,300 gross per month in 2026. That is contextual policy, not the BEST salary and not a confirmed 2027 contract rate. Likewise, current national 2026/27 doctoral registration fees are €398, with €105 CVEC under the applicable enrolment rules. BEST reimbursement, exemption and 2027/28 rates were not established. Confirm these separately rather than treating “fully funded” as a guarantee that every personal or administrative cost is reimbursed. [S17–S19]

Toulbox gives dated indicative Toulouse rents of about €500 for a shared room and €550 for a studio, with possible additional utilities. The university's housing page includes first-arrival doctoral students among eligible applicants for a limited reserved allocation, but explicitly provides no guarantee. Its advertised room/studio rents are lower than private housing, and current quota limits cannot predict availability in 2027. Do not build the budget around receiving subsidised housing or CAF support. [S20–S21]

A conservative planning scenario, not a quote, is €500–800 rent, €200–300 food, €90–150 utilities/internet, €30–60 transport and €90–170 other recurring expenses, plus about €42 monthly equivalent for current registration/CVEC. Rounded total: approximately €950–1,550 per month. The rent baseline is locally sourced; several other bands are deliberate prudential assumptions for an employed adult, beyond generic student tariffs. They exclude dependants, Canadian accommodation, major travel and start-up costs. At the published €2,800 before-income-tax reference, the arithmetic gap is about €1,250–1,850 before income tax and exceptional costs; it is not forecast disposable income, and the mobility allowance is excluded from that comparison. [S19–S21, S26]

Keep a separate arrival reserve for flights, temporary accommodation, deposits, furnishings, insurance and any gap before first payroll. University guidance gives an indicative €1,200 housing-installation figure based on older estimates; a personal reserve should be built from actual quotes. Confirm Canada travel/accommodation reimbursement, advance payments and the risk of paying two rents. Researcher support can help with these administrative questions, but does not grant a visa or accommodation. [S21–S23]

Applicant fit and preparation, including China

The specific offer requires a master's or equivalent held by 23 November 2026, no doctoral degree, English at B2, and compliance with the France mobility rule. It specifies knowledge of DNA-repair pathways and secondary DNA structures, alongside experience categories including tissue culture, imaging, molecular biology and protein detection. These are more concrete than a generic interest in cancer research. A chemistry applicant should demonstrate understanding of cellular interpretation; a biology applicant should show readiness to work across ligand chemistry and quantitative readouts. None of these statements supplies experimental procedures. [S01–S02]

The European Commission's COFUND doctoral rules permit researchers of any nationality. The project/call lists academic, language and mobility conditions without an observed China-specific exclusion. A Chinese national can therefore be considered eligible in principle, conditional on degree recognition, the personal residence/activity history, language evidence and the employer's complete checks. The postdoctoral third-country nationality exception on the Commission page is not a doctoral restriction. This is not a claim that a particular Chinese degree is automatically equivalent, that the guide contains no additional conditions, or that a visa is guaranteed. [S01–S03, S16]

Mobility is assessed against the call deadline, unlike the hiring-date rule often used in Doctoral Networks: no more than twelve months of residence or main activity in France during the thirty-six months before 23 November 2026, with the exclusions stated in the call. A student currently outside France may satisfy it, but nationality alone proves nothing. Prepare dated evidence of residence, study and employment, and ask the helpdesk about ambiguous periods. Candidates completing a master's in 2027 would miss the stated degree deadline even though employment starts later. [S01–S03, S16]

For an employed non-EU doctoral researcher, official French guidance describes a hosting-agreement-based researcher-talent route for master's-level applicants. The institution must establish the appropriate paperwork and the consulate assesses the application. The read page is general guidance, not a China-specific checklist. A French permit also does not by itself settle permission to conduct research in Canada. Confirm the Canadian activity classification and documents once the mobility plan is known. [S23]

Prepare a compact evidence-led application: degree/transcript and recognised translations, an English CV, a motivation statement addressing the binding-to-cellular-mechanism gap, and a clear account of personally completed work and quantitative analysis. The complete mandatory document list, reference-letter format and language-test/waiver policy still need the official guide or helpdesk. A useful research discussion would explain how to distinguish alternative interpretations of a measurement and how to learn missing skills, without presenting an elaborate experiment plan. The IPBS call asks candidates to contact the institute before applying, with subject BEST call – Dennis Gomez, then use the official online route. [S01–S03]

Career and transferable skills

The resulting skills plausibly transfer to chemical biology, assay development, target validation, imaging and proteomic analysis. This is a skills-based inference, not a verified job offer. The corrected French national follow-up reports 94% employment among active 2020 PhD graduates three years after graduation, but stable employment was revised down to 66.1% among employed graduates. These are historical, all-discipline population figures; they are neither IPBS outcomes nor an individual applicant's probability. Academic progression may require further fixed-term research positions, while industry choices depend on technical depth, communication and demonstrable data quality. [S25]

Risks, verification questions and decision

The deadline date is consistent, but the university-authored programme posting says noon Paris time and also labels November as UTC+2; a saved EURAXESS listing says 10:00 UTC. The IPBS and central call pages give the date only. Do not convert those inconsistent hours into a definitive China-time cutoff. Obtain the portal/helpdesk answer and submit ahead of the final day. Similarly, the central planned 1 September start and the individual September/October range should be reconciled in an offer letter. [S01–S03, S15]

Questions with a direct effect on the decision:

1. Is this exact Gomez–Petitjean topic still accepting candidates, and what is the authoritative deadline hour/time zone?
2. Which institution signs the contract, which doctoral school awards the degree, and is any cotutelle/double-degree agreement intended?
3. What gross and after-deduction payroll corresponds to the indicative €2,800 before income tax, and how is the €350 allowance paid or restricted?
4. Are registration/CVEC, conferences, research facilities and Canada mobility funded separately; are expenses advanced?
5. How long is the Canadian visit, when does it occur, and what immigration/insurance and dual-housing arrangements apply?
6. What proof establishes a Chinese master's equivalence and B2 English, and are any additional guide conditions applicable?
7. How are borderline France residence/activity periods calculated, and which documents are required?
8. How do the supervisors divide meetings, training and research decisions; what is the fallback thesis contribution if the preliminary mechanism hypothesis fails?
9. What are the publication/IP/data-sharing rules across France and Canada, and how are doctoral outputs and authorship agreed?
10. What happens if completion exceeds the funded thirty-six months? Decision: prioritise this opportunity for an applicant already grounded in DNA repair, nucleic-acid structures or chemical biology and comfortable with international mobility. Its value is the complementary mechanism-focused training and relevant infrastructure. The next decisive step is an institute/helpdesk clarification of eligibility documentation, contract pay and joint supervision, followed by a tailored application. Candidates without the required master's by the call deadline or with incompatible France mobility should not invest in a full application. The general financial reference looks workable for a single person in Toulouse, but acceptance should depend on actual contract and mobility costs, not an advertised net-before-tax figure.

Evidence and Sources

The saved recruitment materials do not establish whether this exact project is currently accepting applications. They also differ on the deadline hour and time-zone wording, so no reliable China-time cutoff can be derived. The central BEST first call opened on 21 September 2026; that date does not establish when this individual thesis was first published.

This dossier draws on 26 institutional, government and original-research sources. The reading depth for the three recent original papers is stated individually above; Miron et al. is abstract-level only. The programme guide interior and paper supplements were not read, and some complete papers were unavailable. Clinical-development background does not establish a treatment recommendation.

• S01 Dennis Gomez BEST thesis offer
• S02 IPBS current BEST recruitment call
• S03 University of Toulouse central BEST programme
• S04 Deciphering & Drugging DNA Repair team
• S05 Anne Petitjean current faculty profile
• S06 Petitjean research interests
• S07 Petitjean selected publications
• S08 Miron et al. (2022) platinum G4 binder family
• S09 Boissieras et al. (2024) iMab specificity
• S10 Pipier et al. (2024) three-way DNA junction ligands
• S11 Demange et al. (2022) SDR chemical mechanism
• S12 IPBS core facilities
• S13 IPBS TRI-Genotoul imaging infrastructure
• S14 TIRIS thematic pillars
• S15 University of Toulouse, BEST first-call doctoral employment notice, published 21 September 2026; programme-level pay and deadline wording, with an expired notice label.
• S16 European Commission COFUND action rules
• S17 French national doctorate funding
• S18 French national doctorate framework
• S19 Government enrollment fees 2026/27
• S20 Toulbox local housing FAQ
• S21 University international housing
• S22 Toulouse international researcher support
• S23 Campus France researcher-talent visa
• S24 Toulouse official Shanghai 2026 interpretation
• S25 French doctoral employment 2020 cohort follow-up
• S26 Campus France indicative living expenses 2025